共 333 条
[6]
Neflamapimod: Clinical Phase 2b-Ready Oral Small Molecule Inhibitor of p38α to Reverse Synaptic Dysfunction in Early Alzheimer's Disease
[J].
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE,
2017, 4 (04)
:273-278